Literature DB >> 22765654

The association between contact sensitization and atopic disease by linkage of a clinical database and a nationwide patient registry.

J P Thyssen1, J D Johansen, A Linneberg, T Menné, K Engkilde.   

Abstract

BACKGROUND: Experimental studies have shown that individuals with atopic dermatitis are likely to have suppressed contact sensitivity secondary to their disease whereas some clinical and epidemiological studies have shown that individuals with atopic dermatitis might have a higher prevalence of contact sensitization than controls. The objective was to study the association between contact sensitization and, respectively, atopic dermatitis and asthma using clinical databases.
METHODS: Record linkage of two different registers was performed: (i) a tertiary hospital register of dermatitis patient's patch tested for contact sensitivity and (ii) the Danish National Patient Register containing nationwide hospital discharge diagnoses and outpatient contacts.
RESULTS: An inverse association was found between contact sensitization and, respectively, presumed severe atopic dermatitis (OR, 0.70; 95% CI, 0.61-0.81) and asthma (OR, 0.61; 95% CI, 0.42-0.90) when linkage was performed. Inverse associations were found for all groups of chemicals and metals except for sensitization to fragrances and topical drugs where positive associations were identified. A significant positive association between fragrance sensitization and presumed mild-moderate atopic dermatitis was also found when data from hospital register only were used, suggesting an overall higher prevalence of fragrance sensitization in patients with atopic dermatitis.
CONCLUSIONS: Our findings support that patients with severe atopic dermatitis and asthma have an overall lower prevalence of contact sensitization when compared with controls, whereas mild-to-moderate disease does not suppress contact sensitization. The prevalence of contact sensitization to fragrance chemicals was higher in patients with atopic dermatitis. Patients should be instructed to avoid scented moisturizers and products containing highly sensitizing substances.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22765654     DOI: 10.1111/j.1398-9995.2012.02863.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

1.  Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis.

Authors:  Sharon E Jacob; Maria McGowan; Nanette B Silverberg; Janice L Pelletier; Luz Fonacier; Nico Mousdicas; Doug Powell; Andrew Scheman; Alina Goldenberg
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

2.  Nickel allergy is associated with wheezing and asthma in a cohort of young German adults: results from the SOLAR study.

Authors:  Laura Kolberg; Felix Forster; Jessica Gerlich; Gudrun Weinmayr; Jon Genuneit; Doris Windstetter; Christian Vogelberg; Erika von Mutius; Dennis Nowak; Hans Drexler; Torsten Schäfer; Katja Radon
Journal:  ERJ Open Res       Date:  2020-02-03

3.  Prevalence of Atopic Dermatitis Criteria among Textile Workers with Occupational Allergic Contact Dermatitis and Effects of Having Atopic Dermatitis on Contact Antigenic Diversity.

Authors:  Betül Taş; İlknur Kıvanç Altunay
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-02-04

4.  Contact allergy in children with and without atopic dermatitis: An Italian multicentre study.

Authors:  Domenico Bonamonte; Katharina Hansel; Paolo Romita; Anna Belloni Fortina; Giampiero Girolomoni; Gabriella Fabbrocini; Cataldo Patruno; Maddalena Napolitano; Annalisa Patrizi; Giuseppe Argenziano; Giuseppe Micali; Piergiacomo Calzavara Pinton; Caterina Foti; Luca Stingeni
Journal:  Contact Dermatitis       Date:  2022-04-28       Impact factor: 6.419

Review 5.  Atopic Dermatitis: Identification and Management of Complicating Factors.

Authors:  Risa Tamagawa-Mineoka; Norito Katoh
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.